Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Sign in
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Emerging Approaches in Schizophrenia
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
View All
Letter to the Editor
Page 134
Recently published articles about
Letter to the Editor
JCP
Letter to the Editor
Topiramate Produced Weight Loss Following Olanzapine-Induced Weight Gain in Schizophrenia
November 1, 2002
Emmanuelle Levy
,
Howard C. Margolese
,
Guy Chouinard
JCP
Letter to the Editor
Nicotine-Induced Angiogenesis
October 1, 2002
Michael Alan Schwartz
JCP
Letter to the Editor
Reply to Letter to the Editor "Nicotine-Induced Angiogenesis"
October 1, 2002
R. Douglas Shytle
,
Archie A. Silver
,
Paul R. Sanberg
JCP
Letter to the Editor
Severe Hypertriglyceridemia Associated With Olanzapine
October 1, 2002
Steven C. Stoner
,
Beth M. Dubisar
,
Rintu Khan
, et al
PCC
Letter to the Editor
Uses of Newer Anticonvulsants: An Update
October 1, 2002
Timothy R. Berigan
JCP
Letter to the Editor
Injection of Depot Antipsychotic Medications in Patients With Schizophrenia
September 23, 2002
Martin Fleishman
«
1
…
132
133
134
135
136
…
173
»